In its announcement, the agency noted that it will re-evaluate the coverage decision when results are available from the Sudden Cardiac Death in Heart Failure Trial (SCDHeFT).
The results of SCDHeFT also will help to define appropriate patients to receive LVADs.
In its announcement, the agency noted that it will reevaluate the coverage decision when results are available from the Sudden Cardiac Death in Heart Failure Trial (SCDHeFT).